1334493-20-7

Upstream product

• 1241832-99-4 benzyl 4-amino-2-(benzyloxy)benzoate 
• 1241833-16-8 benzyl 2-(benzyloxy)-4-((4-cyclohexylbenzyl)amino)benzoate 
• 1334493-18-3 benzyl 2-(benzyloxy)-4-(N-(4-cyclohexylbenzyl)-2-(2,2,2-trifluoro-N-methylacetamido)acetamido)benzoate 
• 27634-89-5 4-cyclohexylbenzaldehyde 
• 100-39-0 benzyl bromide 
• 65-49-6 4-Aminosalicylic acid 

Downstream Products

• 1334492-85-1 4-(N-(4-cyclohexylbenzyl)-2-(N,2,4,6-tetramethylphenylsulfonamido)acetamido)-2-hydroxy-benzoic acid 
• 1334493-25-2 benzyl 2-(benzyloxy)-4-(N-(4-cyclohexylbenzyl)-2-(N,2,4,6-tetramethylphenylsulfonamido)acetamido)benzoate 
• 1334492-91-9 4-(N-(4-cyclohexylbenzyl)-2-(N-methylquinoline-8-sulfonamido)acetamido)-2-hydroxy-benzoic acid 
• 1334492-95-3 4-(N-(4-cyclohexylbenzyl)-2-(N,1-dimethyl-1H-imidazole-4-sulfonamido)acetamido)-2-hydroxybenzoic acid 
• 1334492-97-5 4-(2-(4-bromo-N-methylphenylsulfonamido)-N-(4-cyclohexylbenzyl)acetamido)-2-hydroxy-benzoic acid 
• 1334493-00-3 4-(2-(4-chloro-N-methylphenylsulfonamido)-N-(4-cyclohexylbenzyl)acetamido)-2-hydroxy-benzoic acid 
• 1334493-05-8 4-(N-(4-cyclohexylbenzyl)-2-(N-methyl-4-nitrophenylsulfonamido)acetamido)-2-hydroxy benzoic acid 
• 1334493-50-3 C₃₉H₃₉N₃O₆S 
• 1334493-53-6 C₃₆H₃₇BrN₂O₆S 
• 1334493-54-7 C₃₆H₃₇ClN₂O₆S 
• 1334493-55-8 C₃₆H₃₇N₃O₈S 
• 1334493-33-2 benzyl 2-(benzyloxy)-4-(N-(4-cyclohexylbenzyl)-2-(N-methylquinoline-8-sulfonamido)acetamido)benzoate 
• 1334492-84-0 4-(N-(4-cyclohexylbenzyl)-2-(N,3-dimethylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid 
• 1334493-22-9 benzyl 2-(benzyloxy)-4-(N-(4-cyclohexylbenzyl)-2-(N,3-dimethylphenylsulfonamido)acetamido)benzoate 

Relevant academic research and scientific papers

Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of STAT protein

In one aspect, the invention relates to substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs, derivatives thereof, and related compounds, which are useful as inhibitors of STAT protein activity; synthetic methods for making the com

Linker Variation and Structure-Activity Relationship Analyses of Carboxylic Acid-based Small Molecule STAT3 Inhibitors

The molecular determinants for the activities of the reported benzoic acid (SH4-54), salicylic acid (BP-1-102), and benzohydroxamic acid (SH5-07)-based STAT3 inhibitors were investigated to design optimized analogues. All three leads are based on an N-met

Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain

Signal transducer and activator of transcription 3 (Stat3) protein is a cytosolic transcription factor that is aberrantly activated in numerous human cancers. Inhibitors of activated Stat3-Stat3 protein complexes have been shown to hold therapeutic promis